Last reviewed · How we verify
NCT06326515: CBT with OUD
Cognitive Behavior Therapy for Depression, Stigmatization, Criminogenic Cognition, and Quality of Life Among Patients With Opioid Use Disorder (OUD): A Randomized Control Trial.
NA trial testing psychoeducation in Psychoeducation in 120 participants. Status unknown.
20 July 2024
Quick facts
| Lead sponsor | Government College University Faisalabad |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 120 |
| Start date | 1 January 2024 |
| Primary completion | 20 July 2024 |
| Estimated completion | 10 September 2024 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- psychoeducation
- Stigma Reduction and Relapse Management
Conditions studied
- Psychoeducation — all drugs for Psychoeducation →
Sponsor
Government College University Faisalabad
Who can join
Adults 20 to 30, any sex, with Psychoeducation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
to investigate the impact of cognitive behavior therapy for psychiatric problems among patients with opioid use disorder with relapse condition. In this randomize control trail (RCT), N=120 patients with relapse condition would be taken. After enrolment patients' eligibility assessment would be completed and then n=60 patients would be allocated to experimental (n=30) and waitlist control (n=30) through random assignment. Patient's age range would be between 20 to 30 years.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06326515
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of psychoeducation
Trials testing the same drug.
- NCT06868602 — Effects of Regular Exercise and Psychoeducation on Quality of Life and Depression in the Treatment of Sarcopenia · NA · completed
- NCT06496399 — Evaluation of the Psychoeducation Program Given to the Elderly Living Alone at Home in Terms of Some Parameters · NA · recruiting
- NCT06536205 — Acceptance-commitment Therapy-based Psychoeducation for Individuals Experiencing Earthquakes · NA · active not recruiting
- NCT07189767 — Effects of Psychoeducation on Pregnant Women With Traumatic Birth Perception · NA · completed
- NCT05646238 — The Effect of Psychoeducation on Dysmenorrhea in Nursing Students · NA · completed
Other Government College University Faisalabad trials
Trials by the same sponsor.
- NCT07456410 — Development and Validation of Psycho-Social Program (PSP) · NA · not yet recruiting
- NCT07119515 — Teletherapy vs. In-Person Cognitive Behavioral Therapy for Generalized Anxiety Disorder · NA · recruiting
- NCT06190106 — Experiences of Psychotherapeutic Outcomes in Women Victims of Domestic Violence · NA · unknown
- NCT06192043 — Cognitive Behavioral Interventions for Motivation, Psychological Distress and Quality of Life Among Individuals With Smo · NA · unknown
- NCT06208111 — A Clinical Trial of Cognitive Behavior Therapy for Depression, Stigmatization, Excessive Worries, and Emotional Manageme · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06326515 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Government College University Faisalabad
- Last refreshed: 22 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06326515.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing